Finasteride's Effect on Semen Parameters: The Andrology Data Reviewed

The finasteride semen question has a complicated evidence base. Several studies show modest semen parameter changes; others show none. Magnitude, reversibility, and what this means for men planning families.

The question of finasteride's effects on male fertility parameters is clinically relevant and has been studied in multiple settings. The data are not uniform, and the conflicting results reflect genuine methodological heterogeneity across studies rather than a simple positive or negative answer.

Mechanism: DHT and spermatogenesis

DHT and testosterone both support spermatogenesis in the testis, though the relative contribution of each varies. Type 2 5-AR (the isoform finasteride inhibits) is expressed in the testis, where it converts intratesticular testosterone to DHT. Inhibition of intratesticular DHT production by finasteride could theoretically affect spermatogenesis by altering the androgenic environment of Sertoli cells and germ cells.

However, intratesticular testosterone levels are extremely high (10–100-fold higher than serum) and largely compensate for reduced DHT through direct androgen receptor activation. The testis is not as dependent on DHT as tissues with lower testosterone-to-DHT conversion rates.

Clinical study results

A key industry-sponsored study (Overstreet et al.) following men on 1mg finasteride for 48 weeks found no statistically significant differences in sperm concentration, motility, or morphology compared to placebo. Several smaller studies and case reports have documented semen parameter decrements — primarily reduced volume and concentration — in a subset of men, particularly at higher doses or in men with pre-existing borderline parameters.

Samplaski et al. (2013) found that men presenting to a male infertility clinic who had been on finasteride had lower semen parameters than drug-naive men, with improvements after discontinuation. Selection bias is a significant confounder here — men presenting to infertility clinics are a non-representative population.

The reversibility data

The most consistent finding across all studies examining this question: semen parameter changes associated with finasteride use are reversible within months of discontinuation. This reversibility distinguishes finasteride effects from irreversible spermatogenic damage and suggests that the drug's effect on spermatogenesis, where present, is functional rather than structural.